DYN – dyne therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $47.00 price target on the stock.
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $31.00 price target on the stock.
We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely [Yahoo! Finance]
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock.
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Form S-8 Dyne Therapeutics, Inc.
Form 8-K Dyne Therapeutics, Inc. For: May 02
Form 10-Q Dyne Therapeutics, Inc. For: Mar 31
Form ARS Dyne Therapeutics, Inc. For: Dec 31
Form DEFA14A Dyne Therapeutics, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.